Facilitating safe transition to home for preterm infants (FAST home): Protocol for a retrospective observational study
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0318309 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2025. Verfasst von Lisa Szatkowski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Perinatal Research, School of Medicine, University of Nottingham, Nottingham, United Kingdom. Hauptthemen laut MEDLINE: Infant, Premature, Patient Discharge. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research for Patient Benefit Programme.
Themen: Neonatologie
Abstract (Originalsprache)
Background
Preterm infants (i.e., those born before 37 completed weeks of pregnancy) often require additional care and are admitted to neonatal units soon after birth. Readiness for discharge home typically requires a level of physiological maturity such that an infant is able to: 1) breathe spontaneously without additional support; 2) maintain their own body temperature; 3) take all their nutritional requirements orally; 4) weighs ≥ 1700g and is gaining weight. Longer hospital stays than necessary can be detrimental to infants, stressful for families, and costly. Currently, little is known about whether, how long and why preterm infants stay in hospital beyond physiological readiness for discharge. Materials and methods We will conduct a retrospective cohort study using data from the National Neonatal Research Database on all infants born at < 37 weeks’ gestational age (GA) admitted to neonatal units in England and Wales from 2016-2022. The day of life and postmenstrual age infants reach each physiological milestone, and the final barrier to discharge, will be identified. We will assess whether the final barrier differs by GA and between neonatal Operational Delivery Networks and summarise the number of days infants remain in hospital after surpassing all physiological milestones. We will explore the characteristics of infants, mothers and neonatal units associated with extended hospital stays beyond physiological readiness for discharge.
Discussion
The results of this study will allow identification of areas to target to help achieve a safe reduction in length of hospital stay and will support the development of evidence-based recommendations to guide optimal discharge practices.
Trial registration
ClinicalTrials.gov NCT06284044
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Perinatal Research, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
- Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom.
- Neonatal Unit, Southampton General Hospital, University Hospital Southampton NHS Trust, Southampton, United Kingdom.
- Parent Collaborator, United Kingdom.
- Neonatal Unit, University Hospitals of Derby and Burton NHS Trust, Derby, United Kingdom.
ORCID-Profile: Lisa Szatkowski, Janine Abramson
Förderung
- Research for Patient Benefit Programme
Zitieren
APA
Szatkowski, L., Abramson, J., Tao, S., Seaton, S. E., Dorling, J., Arellano-Meza, M., Harvey, J., Harvey, T., & Ojha, S. (2025). Facilitating safe transition to home for preterm infants (FAST home): Protocol for a retrospective observational study. PLOS ONE. https://doi.org/10.1371/journal.pone.0318309
Vancouver
Szatkowski L, Abramson J, Tao S, Seaton SE, Dorling J, Arellano-Meza M, et al. Facilitating safe transition to home for preterm infants (FAST home): Protocol for a retrospective observational study. PLOS ONE. 2025. doi:10.1371/journal.pone.0318309
BibTeX
@article{Szatkowski2025,
author = {Szatkowski, Lisa and Abramson, Janine and Tao, Sha and Seaton, Sarah E and Dorling, Jon and Arellano-Meza, Michelle and Harvey, Jane and Harvey, Tom and Ojha, Shalini},
title = {Facilitating safe transition to home for preterm infants (FAST home): Protocol for a retrospective observational study},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0318309}
}
EUVIMED